Tuesday, April 24, 2018
Company News: Page (1) of 1 - 04/11/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Nursing Academy Urges Regulation of Lab-Developed & Direct-to-Consumer Genetic Testing
The American Academy of Nursing recommends actions be taken to increase the regulation of laboratory-developed (LDT) and direct-to-consumer (DTC) genetic testing. Concerns about consumer ease of acces...
(April 11, 2018)

WASHINGTON, DC, April 11, 2018 /PRNewswire-PRWeb/ -- The American Academy of Nursing released a policy brief that recommends actions be taken to increase the regulation of laboratory-developed (LDT) and direct-to-consumer (DTC) genetic testing. Concerns about consumer ease of access to genetic testing include test accuracy, consumer protections from discrimination based on results, and the lack of nursing's role in providing best practices, context and education.

Among the several recommendations in the Academy's policy brief is for the Food and Drug Administration and the Centers for Medicaid and Medicare Services to work with entities that own and market commercial test "kits" or laboratory-developed genetic tests and services regarding the clarity of information provided to consumers.

Genetic testing includes an array of techniques for analyzing human DNA, RNA, and protein. These services range from detecting gene variants associated with a specific disease to paternity testing. The increased ease of access to genetic testing for the general public over the past decade has given rise to issues regarding data storage, testing standards, false-positives, and consumers understanding the true meaning of a test within the context of risk factors. Privacy of the results is also a concern as data could potentially be used in discriminatory practices by insurers and employers.

The Academy's policy brief, "Strengthen Federal Regulation of Laboratory-developed and Direct-To-Consumer Genetic Testing," was published in the Academy's journal, Nursing Outlook.

"The American Academy of Nursing has long advocated for all patients' rights to information, education and privacy related to their health care," said Academy President Karen Cox, PhD, RN, FAAN. "The Academy is interested in working with external stakeholders including consumer organizations to increase nurses' role in genetic education for patients and families and in disseminating best practices for genetic testing for healthcare providers and consumers."

Read the Academy's full policy brief: http://www.nursingoutlook.org/article/S0029-6554(17)30629-2/fulltext

The American Academy of Nursing (http://www.AANnet.org) serves the public and the nursing profession by advancing health policy and practice through the generation, synthesis, and dissemination of nursing knowledge. The Academy's more than 2,500 fellows are nursing's most accomplished leaders in education, management, practice, and research. They have been recognized for their extraordinary contributions to nursing and healthcare.


SOURCE American Academy of Nursing

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Prosumer/Consumer,Storage,Medicine,Disease,Insurance,healthcare,Surgery,Seniors Health,Seniors,Nurse,Insurance Companies,Science,Medical,Biology,Genetics,Medical Professionals,
Related Sites: Oceania ,   DMN Newswire ,   Storage ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • National Oral Health Report: A State Of Decay
  • Global Medical Device Market 2018 with Forecasts to 2023 - Driven by Healthcare Expenditure / Technological Development / Aging Population / Chronic Diseases
  • Orthodontic Supplies Market to Hit 8.9% CAGR to 2023, Led by Align Technology, Inc. (US), 3M Company (US), and Danaher Corporation (US)
  • New Orleans' GAINSWave Offers GAINSWave® in Louisiana
  • Hearing Aids Market Is Estimated To Generate Revenues Worth USD 4.5 Billion By 2024: Grand View Research, Inc.

  • MOLOGEN AG: Announcement of the new dates for the publication of the Annual Financial Statements 2017 and the 2018 Annual General Meeting
  • SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Myriad Genetics, Inc. (MYGN) & Lead Plaintiff Deadline - June 19, 2018
  • Generic Injectables Market to Generate a Revenue of US$ 150 Bn by 2025, Says TMR
  • Anpac Bio Wins 2018 International 'BIG Innovation Award'
  • Health Tourism Market 2018 Global Industry Size, Emerging Trends, Share, Growth Factors, with growing at a CAGR of 15.4% Forecast by 2025

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines